Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Obvious!

Re: Obvious! Moxa, the problem with the U.S. patent system is a different one...

in response to by
posted on Jan 27, 2009 11:03PM

Due to my knowledge, you may get a U.S. patent "easier" compared to a European patent. The checks are done not so "deep" due to the fact that much more patents are filed in the U.S. So the examiners have no chance to go into such deep. It's Ok, as long as nobody cares about the granted patent. Afterwards, the "deep" check is done with the reex.

Best wishes

S40205

Share
New Message
Please login to post a reply